Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Ribosomal protein S7 is both a regulator and a substrate of MDM2.

Zhu Y, Poyurovsky MV, Li Y, Biderman L, Stahl J, Jacq X, Prives C.

Mol Cell. 2009 Aug 14;35(3):316-26. doi: 10.1016/j.molcel.2009.07.014.

2.

Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function.

Chen D, Zhang Z, Li M, Wang W, Li Y, Rayburn ER, Hill DL, Wang H, Zhang R.

Oncogene. 2007 Aug 2;26(35):5029-37. Epub 2007 Feb 19.

PMID:
17310983
3.

Ribosomal protein S7 regulates arsenite-induced GADD45α expression by attenuating MDM2-mediated GADD45α ubiquitination and degradation.

Gao M, Li X, Dong W, Jin R, Ma H, Yang P, Hu M, Li Y, Hao Y, Yuan S, Huang J, Song L.

Nucleic Acids Res. 2013 May 1;41(10):5210-22. doi: 10.1093/nar/gkt223. Epub 2013 Apr 5.

4.

Mdm2 RING mutation enhances p53 transcriptional activity and p53-p300 interaction.

Clegg HV, Itahana Y, Itahana K, Ramalingam S, Zhang Y.

PLoS One. 2012;7(5):e38212. doi: 10.1371/journal.pone.0038212. Epub 2012 May 29.

5.

Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop.

Zhang X, Wang W, Wang H, Wang MH, Xu W, Zhang R.

Oncogene. 2013 May 30;32(22):2782-91. doi: 10.1038/onc.2012.289. Epub 2012 Jul 9.

PMID:
22777350
6.

Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress.

Zhou X, Hao Q, Liao J, Zhang Q, Lu H.

Oncogene. 2013 Jan 17;32(3):388-96. doi: 10.1038/onc.2012.63. Epub 2012 Mar 5.

7.

The RP-Mdm2-p53 pathway and tumorigenesis.

Miliani de Marval PL, Zhang Y.

Oncotarget. 2011 Mar;2(3):234-8. Review.

8.

Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.

Dai MS, Shi D, Jin Y, Sun XX, Zhang Y, Grossman SR, Lu H.

J Biol Chem. 2006 Aug 25;281(34):24304-13. Epub 2006 Jun 27.

9.

Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network.

Daftuar L, Zhu Y, Jacq X, Prives C.

PLoS One. 2013 Jul 16;8(7):e68667. doi: 10.1371/journal.pone.0068667. Print 2013.

10.

MDM2 promotes ubiquitination and degradation of MDMX.

Pan Y, Chen J.

Mol Cell Biol. 2003 Aug;23(15):5113-21.

11.

Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.

Xu C, Fan CD, Wang X.

Oncogene. 2015 Jan 15;34(3):281-9. doi: 10.1038/onc.2013.557. Epub 2014 Jan 13.

PMID:
24413081
12.

Ribosomal protein S3: A multi-functional protein that interacts with both p53 and MDM2 through its KH domain.

Yadavilli S, Mayo LD, Higgins M, Lain S, Hegde V, Deutsch WA.

DNA Repair (Amst). 2009 Oct 2;8(10):1215-24. doi: 10.1016/j.dnarep.2009.07.003. Epub 2009 Aug 4.

13.

Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.

Sun XX, Wang YG, Xirodimas DP, Dai MS.

J Biol Chem. 2010 Aug 13;285(33):25812-21. doi: 10.1074/jbc.M109.098442. Epub 2010 Jun 16.

14.

Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry.

Zhu Y, Regunath K, Jacq X, Prives C.

Genes Dev. 2013 Aug 15;27(16):1739-51. doi: 10.1101/gad.212258.112. Epub 2013 Aug 9.

15.

Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.

Okamoto K, Taya Y, Nakagama H.

FEBS Lett. 2009 Sep 3;583(17):2710-4. doi: 10.1016/j.febslet.2009.07.021. Epub 2009 Jul 18.

16.
17.

Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.

Lindström MS, Jin A, Deisenroth C, White Wolf G, Zhang Y.

Mol Cell Biol. 2007 Feb;27(3):1056-68. Epub 2006 Nov 20.

18.

Mdm2 and MdmX partner to regulate p53.

Wang X, Jiang X.

FEBS Lett. 2012 May 21;586(10):1390-6. doi: 10.1016/j.febslet.2012.02.049. Epub 2012 Mar 8. Review.

19.

Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells.

Wade M, Li YC, Matani AS, Braun SM, Milanesi F, Rodewald LW, Wahl GM.

Oncogene. 2012 Nov 8;31(45):4789-97. doi: 10.1038/onc.2011.625. Epub 2012 Jan 23.

20.

Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination.

Wei J, Yang Y, Lu M, Xu L, Liu F, Yuan Z, Bao Q, Jiang Z, Xu X, Guo X, Zhang X, You Q, Sun H.

Anticancer Agents Med Chem. 2015;16(2):174-89. Review.

PMID:
26343143

Supplemental Content

Support Center